Global Dry Eye Disease Market Report 2022: Increasing Emergence of Novel Treatments Presents Opportunities
December 20, 2022 08:33 ET
|
Research and Markets
Dublin, Dec. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Dry Eye Disease Market By product, By distribution channel & By region-Forecast Analysis 2022-2028" report has been added to ...
Global Age-related Macular Degeneration Market Report 2022 to 2030: High R&D Investments, Product Launches, Rising Age-Related Macular Degeneration (AMD) Prevalence are Driving Growth
December 02, 2022 06:23 ET
|
Research and Markets
Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Age-related Macular Degeneration Market Size, Share & Trends Analysis Report by Product (Eylea, Lucentis, Beovu), by Disease Type (Wet AMD, Dry...
Macular Degeneration Treatment Global Market Report 2022: Continued Development of Advanced Therapies Presents Opportunities
September 08, 2022 07:58 ET
|
Research and Markets
Dublin, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Market Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global macular...
Global Retinal Imaging Devices Market Report 2022: Growing Prevalence of Diabetes Boosting Demand
September 07, 2022 06:58 ET
|
Research and Markets
Dublin, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The "Retinal Imaging Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Device Type, and End-User" report has been added to ...
Global Thyroid Eye Disease Treatments Market Report to 2027 - Featuring AbbVie, Akron and AMRI Global Among Others
July 28, 2022 06:38 ET
|
Research and Markets
Dublin, July 28, 2022 (GLOBE NEWSWIRE) -- The "Thyroid Eye Disease Treatments Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The...
Frontera Therapeutics Completes $160 Million Series B Financing to Fund Clinical Development and Manufacturing Capabilities
July 19, 2022 08:00 ET
|
Frontera Therapeutics
FDA clears Investigational New Drug (IND) application for lead gene therapy product candidate, FT-001, for the treatment of a rare inherited eye disease leading to severe visual impairment that may...
ViGeneron announces follow-on collaboration with Daiichi Sankyo to develop a novel gene therapy for prevalent eye diseases
April 26, 2022 03:00 ET
|
ViGeneron GmbH
The companies agree a follow-on collaboration to evaluate ViGeneron’s adeno-associated virus vectors (vgAAVs) for delivering Daiichi Sankyo’s novel therapeutic protein to treat prevalent eye diseases ...
Using Ultrasound to Treat Dry Eye Disease
March 22, 2022 10:00 ET
|
Experimental Biology and Medicine
WASHINGTON, March 22, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 6, March, 2022) describes a novel treatment for dry eye disease...
Global $22+ Billion Ocular Implants (Glaucoma Implants, Intraocular Lens) Markets to 2030: Increasing Focus on the Development of Technologically Advanced Products is Expected to Drive the Market
March 18, 2022 05:03 ET
|
Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "Ocular Implants Market Size, Share & Trends Analysis Report by Product (Glaucoma Implants, Intraocular Lens), by Application (Glaucoma Surgery,...
Global Bionic Eye Market Research Report 2021 Featuring Nidek, Nano Retina, MetaModa, Pixium Vision, Monash Vision, iBionics & Optobionics
March 10, 2022 04:03 ET
|
Research and Markets
Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Global Bionic Eye Market, By Type (Implant v/s External), By Technology (Electronic v/s Mechanical), By End User (Hospitals, Ophthalmic Clinics,...